Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.3599
-0.0011 (-0.30%)
At close: Nov 3, 2026, 4:00 PM EST
0.3554
-0.0045 (-1.25%)
After-hours: Nov 3, 2026, 7:30 PM EST
Evogene Market Cap
Evogene has a market cap or net worth of $5.6 million as of November 3, 2026. Its market cap has decreased by 50.36% in one year.
Market Cap
5.60M
Enterprise Value
7.34M
1-Year Change
-50.36%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $5.60M, a decrease of -80.00%. That is a compound annual growth rate of -8.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 5.60M | -31.83% |
| Dec 31, 2025 | 8.22M | -36.78% |
| Dec 31, 2024 | 13.00M | -69.10% |
| Dec 31, 2023 | 42.08M | 60.85% |
| Dec 29, 2022 | 26.16M | -63.27% |
| Dec 30, 2021 | 71.23M | -58.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| FibroBiologics | 6.47M |
| Enveric Biosciences | 6.40M |
| Processa Pharmaceuticals | 6.33M |
| Aprea Therapeutics | 6.10M |
| Addex Therapeutics | 6.05M |
| XTL Biopharmaceuticals | 5.90M |
| Alzamend Neuro | 5.84M |
| Skye Bioscience | 5.67M |